Australia markets closed

Imagion Biosystems Limited (IBX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0330+0.0010 (+3.12%)
At close: 03:59PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 1.18M
Enterprise value 3.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.57
Price/book (mrq)3.84
Enterprise value/revenue 2.12
Enterprise value/EBITDA -1.90

Trading information

Stock price history

Beta (5Y monthly) 2.05
52-week change 3-93.12%
S&P500 52-week change 333.56%
52-week high 30.6000
52-week low 30.0220
50-day moving average 30.0340
200-day moving average 30.0814

Share statistics

Avg vol (3-month) 3175.81k
Avg vol (10-day) 3769.01k
Shares outstanding 535.65M
Implied shares outstanding 635.65M
Float 832M
% held by insiders 110.99%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 316 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -106.79%
Operating margin (ttm)-56.43%

Management effectiveness

Return on assets (ttm)-109.93%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)5.92M
Revenue per share (ttm)0.18
Quarterly revenue growth (yoy)137.00%
Gross profit (ttm)N/A
EBITDA -5.48M
Net income avi to common (ttm)-6.32M
Diluted EPS (ttm)-0.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)382.45k
Total cash per share (mrq)0.01
Total debt (mrq)3.19M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.09
Book value per share (mrq)-0.16

Cash flow statement

Operating cash flow (ttm)-2.45M
Levered free cash flow (ttm)-1.33M